Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity

v3.21.1
Stockholders' Equity
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Stockholders' Equity
8. Stockholders’ Equity
The Company is authorized to issue 10,000,000 shares of preferred stock as of December 31, 2020 and 2019, and 200,000,000 and 100,000,000 shares of common stock as of December 31, 2020 and 2019, respectively.
In July 2020, the Company filed a $200.0 million registration statement on Form
S-
3
with the SEC and entered into an
at-the-market
facility (ATM) to sell up to $75.0 million of common stock under the registration statement. To date, the Company has not sold any shares of common stock under the ATM.
The Company had reserved shares of authorized but unissued common stock as follows:
 
    
December 31,
 
    
2020
    
2019
 
2013 Plan
     9,080,230        9,143,863  
2020 Plan
     750,000        —    
    
 
 
    
 
 
 
Total reserved shares of common stock
     9,830,230        9,143,863  
    
 
 
    
 
 
 
Sale of Common Stock
On March 8, 2019, pursuant to a shelf registration statement on Form
S-3,
the Company issued 8,000,000 shares of its common stock at $12.50 per share in an underwritten public offering (referred to as the March 2019 public offering). On March 11, 2019, the underwriters fully exercised their option to purchase additional shares
 
resulting in the issuance of an additional 1,200,000 shares. Net proceeds to the Company from the March 2019 public offering were approximately $107.7 million after deducting underwriting discounts, commissions, and other offering expenses.